tocophersolan has been researched along with Cancer of Stomach in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bai, Y; Chen, L; Fakhri, GE; Gao, H; Wang, M | 1 |
| Chen, GX; Wang, YR; Wei, P; Yang, SY | 1 |
2 other study(ies) available for tocophersolan and Cancer of Stomach
| Article | Year |
|---|---|
Self-Assembly Nanoparticles for Overcoming Multidrug Resistance and Imaging-Guided Chemo-Photothermal Synergistic Cancer Therapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cell Line, Tumor; Doxorubicin; Drug Delivery Systems; Drug Liberation; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Humans; Indocyanine Green; Nanoparticles; Phototherapy; Stomach Neoplasms; Theranostic Nanomedicine; Vitamin E | 2020 |
Barbaloin loaded polydopamine-polylactide-TPGS (PLA-TPGS) nanoparticles against gastric cancer as a targeted drug delivery system: Studies in vitro and in vivo.
Topics: Animals; Anthracenes; Antineoplastic Agents, Phytogenic; Biological Transport; Cell Line, Tumor; Cell Proliferation; Drug Compounding; Drug Delivery Systems; Epithelial Cells; Galactosamine; Humans; Indoles; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Nanoparticles; Polyesters; Polymers; Stomach Neoplasms; Treatment Outcome; Tumor Burden; Vitamin E; Xenograft Model Antitumor Assays | 2018 |